Can-Fite BioPharma Ltd.CANFNYSE
LOADING
|||
PB Ratio: Discounted Valuation
Trending higher, below historical average, slight contraction.
Left:
||||
Price-to-book ratio
Latest
2.09
↓ 53% below average
Average (9y)
4.40
Historical baseline
Range
High:8.67
Low:1.51
CAGR
-4.9%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 2.09 | +37.2% |
| 2023 | 1.52 | -60.3% |
| 2022 | 3.84 | +154.1% |
| 2021 | 1.51 | -56.6% |
| 2020 | 3.48 | -8.5% |
| 2019 | 3.80 | -52.5% |
| 2018 | 8.00 | +1.9% |
| 2017 | 7.85 | -9.5% |
| 2016 | 8.67 | +164.2% |
| 2015 | 3.28 | - |